Antinephrin Autoantibodies: Biomarker for Kidney Disease?
STOCKHOLM — People with difficult to diagnose kidney diseases linked to nephrotic syndrome show uniquely high levels of antinephrin autoantibodies, suggesting a novel biomarker and breakthrough development in diagnosing and managing the diseases. “The discovery of antinephrin autoantibodies thoroughly changes our understanding of idiopathic nephrotic syndrome, minimal change disease (MCD), and primary focal segmental glomerulosclerosis …